drugset / Trial / NCT03860220
The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this study was to assess the efficacy and safety of FDC therapy with triple therapy of Telmisartan 40 mg/Amlodipine 5 mg/Rosuvastatin 10mg in Korean patients with both hypertension and dyslipidemia.
Timeline
- Start
- 2019-04-25
- Primary completion
- 2023-09-07
- Completion
- 2023-09-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 10 mg | — |
| Comparator | Rosuvastatin | Small molecule | 10 mg | — |
| Comparator | Telmisartan | Other / unclassified | 40 mg | — |
| Comparator | Amlodipine | Other / unclassified | 5 mg | — |